Maxlife Drugs Private Limited.
About Maxlife Drugs Private Limited.
Data last updated:
Maxlife Drugs Private Limited. is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 May 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC149174. Its GSTIN is 09AAECM8485A2ZA (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Ganga Saran Sharma and Shashi Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 7 F – 204 Aditya Complex, Preet Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹47,820. For the same year it recorded a net profit of ₹39,120 (net margin 81.8%) and EBITDA of ₹39,120 (EBITDA margin 81.8%). Revenue has declined at a compounded annual rate (CAGR) of 41% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxlife Drugs Private Limited.'s registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 7 F – 204 Aditya Complex, Preet Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maxlife Drugs Private Limited., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxlife Drugs Private Limited is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
Financials of Maxlife Drugs Private Limited.
FY 2025 filings availableMaxlife Drugs Private Limited. reported revenue of ₹47,820 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years. EBITDA rose 521% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39,120 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39,120 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 81.8% | ||||
| Net Profit Margin | 81.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxlife Drugs Private Limited., buy the company report.
Board of directors of Maxlife Drugs Private Limited.
Maxlife Drugs Private Limited has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganga Saran Sharma | Director | 09 Jan 2024 | 2 Years 10 Months | Current |
| Shashi Sharma Also directs: Sharmaa Healthcare Private Limited, Sharmaa Healthcare Research Foundation, Sharma Gold & Silver Private Limited and 2 more | Director | 09 Jan 2024 | 2 Years 10 Months | Current |
| Ankur Sharma Also directs: Sharmaa Healthcare Private Limited, Vvip Infrahome Private Limited, Sharmaa Healthcare Research Foundation and 4 more | Director | 09 Jan 2024 | 2 Years 10 Months | Current |
| Ankit Sharma Also directs: Sharmaa Healthcare Private Limited, Sharmaa Healthcare Research Foundation, Sharmaa Medical & Research Foundation and 3 more | Director | 09 Jan 2024 | 2 Years 10 Months | Current |
| Navneet Bhardwaj | Director | 27 May 2024 | 2 Years 5 Months | Current |
Auditor
Maxlife Drugs Private Limited. is audited by Rajendar K. Kumar & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajendar K. Kumar & Associates | FY 2023 | 010142C |
Shareholding
The shareholding of Maxlife Drugs Private Limited. is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxlife Drugs Private Limited., buy the company report.
Legal cases
No court or tribunal cases involving Maxlife Drugs Private Limited. are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxlife Drugs Private Limited.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxlife Drugs Private Limited has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECM8485A2ZA | Uttar Pradesh | Active | 10 Jul 2024 |
To see the full GST registrations and return filing status of Maxlife Drugs Private Limited., buy the company report.
Recent activity
Maxlife Drugs Private Limited. has 12 board changes on record since 2009: 5 appointments and 7 cessations. The latest: Ankit Sharma ceased to be Additional Director on 29 Sep 2024.
3 earlier events are in the company report.
Frequently asked questions
Maxlife Drugs Private Limited is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 May 2006 (20+ years old) and is registered under CIN U85121DL2006PTC149174.
Maxlife Drugs Private Limited has 5 current directors:
- Ganga Saran Sharma - Director
- Shashi Sharma - Director
- Ankur Sharma - Director
- Ankit Sharma - Director
- Navneet Bhardwaj - Director
The latest financial statements of Maxlife Drugs Private Limited on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxlife Drugs Private Limited is 09AAECM8485A2ZA, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Maxlife Drugs Private Limited is U85121DL2006PTC149174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxlife Drugs Private Limited was incorporated on 25 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Ankit Sharma ceased to be Additional Director on 29 Sep 2024. Ankur Sharma ceased to be Additional Director on 29 Sep 2024. Ganga Saran Sharma ceased to be Additional Director on 29 Sep 2024. Maxlife Drugs Private Limited has 12 board changes on record in total.
The registered office of Maxlife Drugs Private Limited is at Plot No. 7 F – 204 Aditya Complex, Preet Vihar, New Delhi, Delhi, India – 110092.
Maxlife Drugs Private Limited operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Maxlife Drugs Private Limited is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
